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Background: Chronic kidney disease, including end-stage renal disease, has been identified as a possible risk factor
for primary septicemia and wound infection by Vibrio vulnificus. However, cases of severe septicemia, necrotizing
fasciitis, and peritonitis caused by V. vulnificus in patients undergoing continuous ambulatory peritoneal dialysis
(CAPD) have not been described. We report a case of severe septicemia, necrotizing fasciitis, and peritonitis due to
V. vulnificus in a patient undergoing CAPD after ingesting raw seafood.
Case presentation: A 37-year-old woman undergoing CAPD was admitted to the emergency room due to general
weakness, fever, diarrhea, and abdominal pain. Although empirical intraperitoneal antibiotics were administered for
the diagnosis of CAPD-related peritonitis, her fever did not subside. On hospital day 3, she had hemorrhagic bullae
on both lower legs. We evaluated her recent food history, and found that she ate raw seafood before admission.
She underwent emergency fasciotomy on the suspicion of necrotizing fasciitis by V. vulnificus infection. Finally, V.
vulnificus was confirmed by 16S ribosomal ribonucleic acid gene sequencing using blood and peritoneal effluent
fluid cultures. The administration of intraperitoneal ceftazidime and intravenous ciprofloxacin/ceftriaxone was
continued for 4 weeks, and the patient completely recovered.
Conclusions: Suspicion of V. vulnificus infection in vulnerable patients who ingest raw seafood is essential for
prompt diagnosis, which could significantly improve patient outcomes.
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Vibrio vulnificus is a species of gram-negative, motile,
curved, rod-shaped pathogenic bacteria recovered from
estuary, marine, and brackish environments [1]. It was
first identified as a new Vibrio species pathogenic to
humans in 1976 [2]. V. vulnificus infection is one of the
few foodborne illnesses with an increasing incidence [3].
The main clinical manifestations of V. vulnificus infections
are gastrointestinal illness, primary septicemia, and wound
infections. Even with prompt diagnosis and aggressive
therapy, the severity of infection is high, with >90 % of* Correspondence: skimw@chonnam.ac.kr
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fatality rate of 30–50 % [1, 3–5].
Almost all patients with sepsis due to V. vulnificus are
immunocompromised, and the common underlying con-
ditions are alcoholic liver disease, hepatitis B or hepatitis
C or viral-related cirrhosis, diabetes mellitus, and steroid
use [6]. Pre-existing renal disease has been especially
regarded as a risk factor for V. vulnificus infection. Renal
disease might account for up to 7–12 % of primary
septicemia cases [1, 5]. There have been 2 previous case
reports of V. vulnificus peritonitis after consuming or
handling raw seafood in patients undergoing continuous
ambulatory peritoneal dialysis (CAPD) [7, 8]. However,
cases of severe septicemia, necrotizing fasciitis, and peri-
tonitis caused by V. vulnificus in patients undergoingdistributed under the terms of the Creative Commons Attribution 4.0
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of severe septicemia, necrotizing fasciitis, and periton-
itis due to V. vulnificus, which was identified by 16S
ribosomal ribonucleic acid (rRNA) gene sequencing,
in a patient undergoing CAPD after ingesting raw sea-
food. Informed consent was obtained from the patient
and the study protocol was approved by the Institutional
Review Board of Chonnam National University Hospital,
South Korea (CNUH-EXP-2015-129). This study was
conducted according to the principles of the Declaration
of Helsinki.
Case presentation
A 37-year-old woman with end-stage renal disease (ESRD)
secondary to systemic lupus nephritis was admitted to the
emergency room due to general weakness, fever, diarrhea,
and abdominal pain. She had been undergoing CAPD for
15 years. On physical examination, she was found to have
abdominal and rebound tenderness, but no skin wound.
On admission, her body temperature was 38.8 °C, pulse
was 101 beats/min, and blood pressure was 80/40 mmHg.
Redness or discharge at the exit site of the peritoneal
catheter was not observed. The patient had the follow-
ing laboratory findings (reference ranges are indicated
within parentheses): white blood cell (WBC) count of
5.3 × 109/L (4.8–10.8 × 109/L), hemoglobin level of
8.6 g/dL (12–18 g/dL), impaired liver function as
shown by aspartate and alanine transaminase levels of
48 U/L and 16 U/L, respectively (10–37 U/L), C-
reactive protein level of 17.5 mg/dL (0–0.3 mg/dL),
procalcitonin level of 4.23 ng/mL (0–0.5 ng/mL), iron
level of 50 μg/dL (29–164 μg/dL), transferrin saturation
of 43.4 % (25–50 %), and ferritin level of 3207 μg/L
(4.6–274 μg/L). The peritoneal effluent fluid was cloudy
with a WBC count of 560 × 106/L and 55 % poly-
morphonuclear leukocytes. After performing peritoneal
fluid and blood cultures, the patient was treated empir-
ically with intraperitoneal cefazolin (600 mg) and cef-
tazidime (1 g) once daily. Two days after initiating
antibiotic therapy, the abdominal pain subsided and
peritoneal effluent fluid was cleared. However, her body
temperature remained at 39.1 °C. On hospital day 3,
she had severe painful leg edema abruptly. Moreover, she
had cellulitis with ecchymosis and progressive hemorrhagic
bullae on both lower legs. Shortly after, her blood pressure
decreased to 60/40 mmHg. We could conduct any radio-
logical investigations due to cardiovascular instability. She
was then admitted to the intensive care unit. We briefly
evaluated her recent food history, and found that she con-
sumed salted baby octopuses and undercooked cockles few
days before admission. On the suspicion of necrotizing fas-
ciitis by V. vulnificus infection, she underwent emergency
bedside fasciotomy. Wound cultures were performed dur-
ing the fasciotomy, but showed no bacteria growth. Onhospital day 4, peritoneal effluent fluid and blood cultures
performed at admission revealed V. vulnificus. Therefore,
we decided to perform a more accurate identification using
16S rRNA gene sequencing.
Genomic deoxyribonucleic acid was extracted from
the cultivated microorganism using proteinase K. The
16S rRNA gene was successfully amplified with universal
primers (forward: 5′-AGTTTGATCCTGGCTCAG-3′;
reverse: 5′-GTATTGCCGCGGCTGCTG-3′) using Bio-
metra T3000 (Analytik Jena, Göttingen, Germany) and se-
quenced using Applied Biosystems 3130 lx (Applied
Biosystems, Foster City, CA, USA). The 16S rRNA gene
sequences were 100 % homologous to V. vulnificus
(GenBank accession number: KP223908.1), which was
confirmed with nucleotide basic local alignment search
tool analysis. V. vulnificus showed sensitivity to cefotax-
ime, ciprofloxacin, and ceftazidime, intermediate sensi-
tivity to cefazolin, and resistance to cefoxitin using the
broth microdilution methods. Therefore, intraperito-
neal cefazolin was discontinued, but intravenous cipro-
floxacin (200 mg twice a day) and cefotaxime (1 g every
24 h) were administered in addition to intraperitoneal
ceftazidime (1 g once daily) after dose adjustment for
renal insufficiency. After 7 days of treatment, the periton-
eal effluent WBC count decreased to 3 × 106/L. Further-
more, the absence of bacterial growth was confirmed with
follow-up blood and peritoneal fluid cultures. The intra-
peritoneal and intravenous antibiotics were continued
for 4 weeks. The patient underwent additional debride-
ment for granulation tissues in both lower legs after
emergency fasciotomy, and her wound completely
healed after 9 months. The patient had been advised to
avoid consumption of raw and uncooked seafood, and
use separate cutting boards and knives for seafood and
non-seafood. Furthermore, she was instructed to wear
gloves when handling raw oysters or shellfish.
Conclusions
V. vulnificus is an opportunistic human pathogen trans-
mitted from seawater, raw oyster, and shellfish. The
spectrum of disease can vary from gastroenteritis to se-
vere septicemia and necrotizing fasciitis.
Patients with certain underlying medical conditions
are susceptible to V. vulnificus infections. Patients with
alcoholic liver disease, diabetes mellitus, gastrointestinal
and hematologic disorder, malignancy, and iron overload
states have a higher risk of infection [9]. Moreover, kidney
diseases, including ESRD, are regarded as other potential
contributing risk factors for V. vulnificus infection. Func-
tional abnormalities of neutrophils, monocytes, dendritic
cells, and lymphocytes have been observed in uremia,
which makes patients prone to specific life-threatening in-
fections [10]. In addition, dialysis patients have frequently
elevated iron levels because of blood transfusion or iron
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facilitate V. vulnificus infection by enhancing the growth
of the organism and possibly reducing the activity of neu-
trophils [11]. V. vulnificus grows rapidly when transferrin
saturation exceeds 70 % [12]. In this context, a relatively
high transferrin saturation in our patient might be an
additional risk factor for infection.
V. vulnificus infection has not been well described in
patients undergoing peritoneal dialysis. Interestingly,
there are only 2 case reports of V. vulnificus peritonitis
after consuming or handling seafood in patients under-
going CAPD, and these patients completely recovered
after oral and intraperitoneal antibiotic treatments [7, 8].
Similarly, our patient showed peritonitis after ingesting
raw seafood. The proportion of V. vulnificus infections
in Korea and the United States has rapidly increased
during the last decade due to the increased consumption
of raw fish or shellfish [1, 3]. Although previous reports
of V. vulnificus peritonitis, including our report, were
conducted in Asia, patients undergoing CAPD and live
in an area with high incidence of V. vulnificus infection
should avoid raw or undercooked seafood to prevent in-
fection. A remarkable finding about our case was that
peritonitis was followed by severe septicemia and necro-
tizing fasciitis. We could presume that V. vulnificus in
the peritoneal fluid might penetrate the peritoneum or
bowel wall into the blood stream, which results in septi-
cemia. Therefore, peritonitis might be an important clin-
ical manifestation of V. vulnificus infection in peritoneal
dialysis patients. Furthermore, according to our findings,
patients undergoing peritoneal dialysis are highly suscep-
tible to various degrees of V. vulnificus infection from
peritonitis to septicemia and necrotizing fasciitis.
An array of phenotypic and genomic techniques has
become available for the identification of Vibrio species.
However, Vibrio and other closely related species show
similar phenotypic features and are not easily distin-
guished biochemically [13]. The identification of Vibrios
isolated from the aquaculture environment has been im-
precise and requires many biochemical and/or physio-
logical tests. Although the 16S rRNA gene sequencing
method may be less reliable because many different spe-
cies within the genus Vibrio may contain identical 16S
rRNA gene sequences, it remains one of the most com-
monly used methods for bacterial identification [14]. 16S
rRNA gene sequencing can be used in hospitals to iden-
tify V. vulnificus that are difficult to identify using
phenotypic and biochemical methods.
Moreover, the recommended antibiotic therapy for V.
vulnificus is tetracycline family (e.g. tetracycline, doxycyc-
line, and minocycline) plus third-generation cephalosporin
[15]. Alternative antibiotics therapies are cefotaxime or
ciprofloxacin [1]. In a recent retrospective study, fluoro-
quinolones were found to be the best option for theantibiotic treatment of necrotizing fasciitis caused by V.
vulnificus [16]. Therefore, fluoroquinolones or tetracycline
plus third-generation cephalosporin could be prescribed
empirically in a patient with severe V. vulnificus infection.
Despite reports of high mortality from V. vulnificus
infection, our patient recovered without complication.
Necrotizing fasciitis is a life threatening soft tissue infec-
tion with a high mortality rate, which requires emergent
surgical fasciotomy, debridement, and broad-spectrum
antibiotic treatment when the diagnosis is confirmed
[17]. Consequently, early surgical intervention was per-
formed and adequate antibiotics treatments were admin-
istered to our patient; these strategies might dramatically
improve the patient’s survival. Finally, suspicion of V.
vulnificus infection in vulnerable patients who ingest
raw seafood is essential for prompt diagnosis, which
could significantly improve patient outcomes.
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